PDCD1LG2 and neoplasm: Moreover, stage III and IV patients who received postoperative chemotherapy with low tumor PD-L2 levels presented an increased risk for poor OS after adjustment for age, pT stage, LVI, PNI and tumor location (Fig. 2D,F).